Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2011-03-08
2011-03-08
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C514S114000, C548S414000, C564S015000
Reexamination Certificate
active
07902175
ABSTRACT:
Compounds of formula I:wherein R1, R2, n and m are as defined in the specification, processes for their production, their uses and pharmaceutical compositions containing them.
REFERENCES:
patent: 6437165 (2002-08-01), Mandala et al.
patent: 7173058 (2007-02-01), Muller et al.
patent: 2005/0026976 (2005-02-01), Curtin et al.
patent: 2005-538169 (2005-12-01), None
patent: 2006-524660 (2006-11-01), None
patent: 02/18395 (2002-03-01), None
patent: 02/076995 (2002-10-01), None
patent: 2004/024673 (2004-03-01), None
Maiereanu, C. et al., Ring-chain tautomerism and other versatile behaviour of 1,4-dimino-and 1,2-phenylene derivatives of some C-substituted serinols, 2002, Tetrahedron, 58, 2688.
Mandala et al., “Alterations of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists”, Science, vol. 296, No. 556, (2002), pp. 346-349.
Albert Rainer
Francotte Eric
Zecri Frederic
Zollinger Markus
Bianchi Kristin
Chapman Jennifer
DeBenedictis Karen
McAvoy Cozette M.
Novartis AG
LandOfFree
Aminopropanol derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminopropanol derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminopropanol derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2722889